However, since TVP23A was exceptionally found to be upregulated in the majority of CE cases regardless of the number of CD138-positive cells, this gene represents a candidate marker useful for the development of a novel molecular diagnostic method for CE. This evidence concerns the gene SDC1 and cholesteryl ester measurement.